Femi-Comfort Neuromod
2.000,00 AED
Includes:
– 1 ml per sessionPain-modulating neuromuscular therapy.
Get an extra 4% discount when you purchase this product from our mobile app!
Description
Description
Femi-Comfort Neuromod is a targeted therapeutic protocol designed to relieve pelvic and intimate discomfort through advanced neuromuscular pain modulation. This innovative therapy works by regulating nerve–muscle communication to reduce pain signals, relax tense tissues, and restore natural comfort.
How It Works:
- Controlled neuromuscular stimulation is applied to affected pelvic areas.
- The therapy interrupts pain signaling pathways and promotes muscle relaxation.
- Enhances circulation and supports tissue recovery for lasting relief.
Who Can Benefit:
- Women experiencing chronic pelvic pain.
- Discomfort during daily activity or intimacy.
- Postpartum pelvic sensitivity.
- Muscle-related pelvic tension.
- Recovery after gynecological procedures.
Benefits:
- Effective pain reduction without medication.
- Improved muscle relaxation and mobility.
- Enhanced comfort and quality of life.
- Non-invasive and clinically guided.
- Safe with minimal downtime.
Reviews (0)
Show only reviews in English (0)
Be the first to review “Femi-Comfort Neuromod” Cancel reply
SKU:
PRE2967
Category: Women Health
Related products
-20%
Select options
This product has multiple variants. The options may be chosen on the product page
Femi-Dermal Repair LASER
1.200,00 AED – 2.880,00 AEDPrice range: 1.200,00 AED through 2.880,00 AED-20%
Select options
This product has multiple variants. The options may be chosen on the product page
Femi-Scar Restore
1.200,00 AED – 1.920,00 AEDPrice range: 1.200,00 AED through 1.920,00 AED-20%
Select options
This product has multiple variants. The options may be chosen on the product page
Femi-Tight RF (internal)
800,00 AED – 2.560,00 AEDPrice range: 800,00 AED through 2.560,00 AED-20%
Select options
This product has multiple variants. The options may be chosen on the product page




Reviews
There are no reviews yet.